US EditionBioMed X and Servier launch Europe’s first XSeed Labs to advance AI-powered antibody design - Pharmafile
Summary by pharmafile.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
BioMed X and Servier launch Europe’s first XSeed Labs to advance AI-powered antibody design - Pharmafile
BioMed X and Servier have announced the launch of Europe’s first XSeed Labs research project, located at the Spartners incubator in Paris-Saclay, France. The initiative, hosted within Servier’s research site and operated by BioLabs, will develop an AI-enabled platform for sterically-guided bispecific antibody design. The XSeed Labs model, pioneered by BioMed X, brings together scientists […] The post BioMed X and Servier launch Europe’s first XS…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
